116 related articles for article (PubMed ID: 32842611)
1. MDA-MB-231 Breast Cancer Cells Resistant to Pleurocidin-Family Lytic Peptides Are Chemosensitive and Exhibit Reduced Tumor-Forming Capacity.
Hilchie AL; Gill EE; Coombs MRP; Falsafi R; Hancock REW; Hoskin DW
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32842611
[TBL] [Abstract][Full Text] [Related]
2. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts.
Hilchie AL; Doucette CD; Pinto DM; Patrzykat A; Douglas S; Hoskin DW
Breast Cancer Res; 2011 Oct; 13(5):R102. PubMed ID: 22023734
[TBL] [Abstract][Full Text] [Related]
3. Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma.
Hilchie AL; Sharon AJ; Haney EF; Hoskin DW; Bally MB; Franco OL; Corcoran JA; Hancock REW
Biochim Biophys Acta; 2016 Dec; 1858(12):3195-3204. PubMed ID: 27693190
[TBL] [Abstract][Full Text] [Related]
4. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
5. Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells.
Tanaka T; Dancheck BL; Trifiletti LC; Birnkrant RE; Taylor BJ; Garfield SH; Thorgeirsson U; De Luca LM
Mol Cell Biol; 2004 May; 24(9):3972-82. PubMed ID: 15082790
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
[TBL] [Abstract][Full Text] [Related]
7. Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2
Yi J; Chen S; Yi P; Luo J; Fang M; Du Y; Zou L; Fan P
Oncol Res; 2020 Dec; 28(5):519-531. PubMed ID: 32727638
[TBL] [Abstract][Full Text] [Related]
8. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.
Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH
Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807
[TBL] [Abstract][Full Text] [Related]
9. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
Huang MB; Gonzalez RR; Lillard J; Bond VC
Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy-Resistant Breast Cancer Cells Enhance Tumor Progression by Enhancing Premetastatic Niche Formation through the HIF-1α-LOX Axis.
Ko YS; Rugira T; Jin H; Joo YN; Kim HJ
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126606
[TBL] [Abstract][Full Text] [Related]
11. Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat.
Tripathi AK; Kumari T; Tandon A; Sayeed M; Afshan T; Kathuria M; Shukla PK; Mitra K; Ghosh JK
Acta Biomater; 2017 Jul; 57():170-186. PubMed ID: 28483698
[TBL] [Abstract][Full Text] [Related]
12. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
[TBL] [Abstract][Full Text] [Related]
13. Development of the CK-MB-1 trastuzumab-resistant HER2-positive breast cancer cell line and xenograft animal models.
Chung WP; Huang WL; Liao WA; Huang WL; Liu YY; Su WC
Cancer Med; 2021 Apr; 10(7):2370-2379. PubMed ID: 33665980
[TBL] [Abstract][Full Text] [Related]
14. Enhanced killing of breast cancer cells by a d-amino acid analog of the winter flounder-derived pleurocidin NRC-03.
Hilchie AL; Haney EF; Pinto DM; Hancock RE; Hoskin DW
Exp Mol Pathol; 2015 Dec; 99(3):426-34. PubMed ID: 26344617
[TBL] [Abstract][Full Text] [Related]
15. Peptide 18-4/chlorin e6-conjugated polyhedral oligomeric silsesquioxane nanoparticles for targeted photodynamic therapy of breast cancer.
Kim YJ; Lee HI; Kim JK; Kim CH; Kim YJ
Colloids Surf B Biointerfaces; 2020 May; 189():110829. PubMed ID: 32036332
[TBL] [Abstract][Full Text] [Related]
16. HER2-targeted hybrid peptide that blocks HER2 tyrosine kinase disintegrates cancer cell membrane and inhibits tumor growth in vivo.
Kawamoto M; Horibe T; Kohno M; Kawakami K
Mol Cancer Ther; 2013 Apr; 12(4):384-93. PubMed ID: 23358664
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.
Zheng P; Dong L; Zhang B; Dai J; Zhang Y; Wang Y; Qin S
Histochem Cell Biol; 2019 Oct; 152(4):281-291. PubMed ID: 31352515
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer.
Soudy R; Etayash H; Bahadorani K; Lavasanifar A; Kaur K
Mol Pharm; 2017 Mar; 14(3):593-604. PubMed ID: 28157321
[TBL] [Abstract][Full Text] [Related]
19. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
20. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.
Zhao YZ; Dai DD; Lu CT; Chen LJ; Lin M; Shen XT; Li XK; Zhang M; Jiang X; Jin RR; Li X; Lv HF; Cai L; Huang PT
Cancer Lett; 2013 Mar; 330(1):74-83. PubMed ID: 23186833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]